Nanomedicine (Future Medicine journal)
 | |
| Discipline | Nanomedicine |
|---|---|
| Language | English |
| Edited by | Kostas Kostarelos, Charles R. Martin |
| Publication details | |
| History | 2006–present |
| Publisher | |
| Frequency | Biweekly |
| 4.727 (2016) | |
| Standard abbreviations | |
| ISO 4 | Nanomedicine (Lond.) |
| Indexing | |
| CODEN | NLUKAC |
| ISSN | 1743-5889 (print) 1748-6963 (web) |
| OCLC no. | 503720580 |
| Links | |
Nanomedicine is a biweekly peer-reviewed medical journal covering research on medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems, and nanorobotics applications in medicine. It was established in 2006 and is published by Future Medicine. The editors-in-chief are Kostas Kostarelos (University of Manchester) and Charles R. Martin (University of Florida).
Abstracting and indexing[edit]
The journal is abstracted and indexed in the Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences,[1] Embase/Excerpta Medica,[2] Inspec,[3] Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded,[1] and Scopus.[4] According to the Journal Citation Reports, the journal has a 2016 impact factor of 4.727, ranking it 20th out of 158 journals in the category "Biotechnology & Applied Microbiology"[5] and 24th out of 86 journals in the category "Nanoscience & Nanotechnology".[6]
References[edit]
- ^ a b "Master Journal List". Intellectual Property & Science. Thomson Reuters. Retrieved 2015-05-16.
- ^ "Journal titles covered in Embase". Embase. Elsevier. Retrieved 2015-05-16.
- ^ "Inspec list of journals" (PDF). Inspec. Institution of Engineering and Technology. Retrieved 2015-05-16.
- ^ "Content overview". Scopus. Elsevier. Retrieved 2015-05-16.
- ^ "Journals Ranked by Impact: Biotechnology & Applied Microbiology". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.
- ^ "Journals Ranked by Impact: Nanoscience & Nanotechnology". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.